TREM2 and Alzheimer disease: Microglial activation driven by NF-κB (RelA) and cytokine signaling is reported in data from microglia isolated from a tau transgenic mouse model (rTg4510) of AD where downstream differential expression of TREM2 and APOE was also observed (87).